Page results
-
UCLH has treated the first brain cancer patient with immunotherapy prior to standard treatment as part of a pioneering trial.
-
A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
Exhibition co-curated by Healthcare Arts Collective and UCLH Arts and Heritage 25th August - 20th October 2021, UCH Street Gallery, 235 Euston Road
-
Breakthroughs in Alzheimer’s disease are exciting and invigorating dementia research, and we will need to be ready to deliver new treatments as they come through, say Professor Nick Fox and Dr Catherine Mummery.
-
UCLH is making the change from single use to named reusable fabric theatre hats for staff working in operating theatres.
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
New precision therapy for bile duct cancer extends patients’ lives
-
Information about endovascular treatments of AVMs undertaken in the NHNN angiography suite.
-
Information about coil embolisations and how endovascular treatment is used to treat cerebral aneurysms.
File results
-
FOI/2023/0916 - Gender options on patient forms
-
FOI/2023/0917 - Patient Initiated Digital Mutual Aid System (PIDMAS)
-
FOI/2023/0921 - Trust provider for sexual health platform
-
FOI/2023/0923 - Proton Beam Therapy treatments
-
FOI/2023/0925 - Stereotactic radiosurgery treatment/ gamma knife treatment
-
FOI/2023/0926 - Electronic Patient Record Supplier (EPR) contract
-
FOI/2023/0930 - Patient deaths while on waiting list 2018-2023
-
FOI/2023/0931 - Trust surgical and equipment drape usage in theatre departments
-
FOI/2023/0934 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0936 - Policy and Procedure management at Trust